Pulse Biosciences, Inc. (PLSE)Healthcare | Medical Instruments & Supplies | Miami, United States | NasdaqCM
23.40 USD
+2.89
(14.091%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 23.20 -0.20 (-0.205%) ⇩ (April 17, 2026, 5:48 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:12 p.m. EDT
PLSE is a high-risk stock with significant volatility and weak fundamentals. The recent price history shows a fluctuating trend, with a recent dip to $18.67, but the stock has shown some resilience. However, the lack of dividends, negative earnings, and high debt-to-equity ratio indicate poor financial health. While there is some positive news regarding clinical studies and leadership changes, the overall outlook remains uncertain. Short-term traders might consider the recent dip as a potential buying opportunity, but long-term investors should be cautious due to the lack of fundamentals and high risk. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.316167 |
| MSTL | 0.329508 |
| AutoETS | 0.337803 |
| AutoARIMA | 0.337804 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 64% |
| H-stat | 1.65 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.203 |
| Excess Kurtosis | -0.80 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.336 |
| Revenue per Share | 0.005 |
| Market Cap | 1,590,944,384 |
| Forward P/E | -27.21 |
| Beta | 1.69 |
| Website | https://www.pulsebiosciences.com |
As of April 11, 2026, 4:12 p.m. EDT: Options activity suggests mixed signals. Calls show some interest in higher strikes, particularly around 23.0 and 25.0, with higher IV and OI, indicating potential bullish sentiment for the longer term. However, puts show more activity in lower strikes, such as 11.0 and 13.0, with higher IV and OI, suggesting some bearish sentiment. The overall options data indicates a cautious outlook with potential for both upward and downward movements, but with limited clarity on the direction.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.18623483 |
| Address1 | 601 Brickell Key Drive |
| Address2 | Suite 1080 |
| All Time High | 45.82 |
| All Time Low | 1.18 |
| Ask | 27.84 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 265,730 |
| Average Daily Volume3 Month | 351,293 |
| Average Volume | 351,293 |
| Average Volume10Days | 265,730 |
| Beta | 1.694 |
| Bid | 16.6 |
| Bid Size | 2 |
| Board Risk | 10 |
| Book Value | 1.189 |
| City | Miami |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 23.4 |
| Current Ratio | 10.529 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 23.4 |
| Day Low | 21.3 |
| Debt To Equity | 9.336 |
| Display Name | Pulse Biosciences |
| Earnings Call Timestamp End | 1,771,536,600 |
| Earnings Call Timestamp Start | 1,771,536,600 |
| Earnings Timestamp | 1,771,534,800 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -75,868,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -20.005 |
| Enterprise To Revenue | 4,336.398 |
| Enterprise Value | 1,517,739,392 |
| Eps Current Year | -0.85 |
| Eps Forward | -0.86 |
| Eps Trailing Twelve Months | -1.08 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 20.7476 |
| Fifty Day Average Change | 2.652399 |
| Fifty Day Average Change Percent | 0.12784125 |
| Fifty Two Week Change Percent | 18.623484 |
| Fifty Two Week High | 26.3 |
| Fifty Two Week High Change | -2.8999996 |
| Fifty Two Week High Change Percent | -0.11026615 |
| Fifty Two Week Low | 12.56 |
| Fifty Two Week Low Change | 10.839999 |
| Fifty Two Week Low Change Percent | 0.86305726 |
| Fifty Two Week Range | 12.56 - 26.3 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,463,578,200,000 |
| Float Shares | 17,794,101 |
| Forward Eps | -0.86 |
| Forward P E | -27.209301 |
| Free Cashflow | -29,515,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 116 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | -0.54 |
| Gross Profits | -189,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.73703 |
| Held Percent Institutions | 0.09518 |
| Implied Shares Outstanding | 67,989,078 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida. |
| Long Name | Pulse Biosciences, Inc. |
| Market | us_market |
| Market Cap | 1,590,944,384 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_276735354 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -72,781,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,590,944,425 |
| Number Of Analyst Opinions | 2 |
| Open | 21.3 |
| Operating Cashflow | -54,122,000 |
| Operating Margins | -69.14015 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 510-906-4600 |
| Post Market Change | -0.20470047 |
| Post Market Change Percent | -0.87478834 |
| Post Market Price | 23.1953 |
| Post Market Time | 1,776,462,488 |
| Previous Close | 20.51 |
| Price Eps Current Year | -27.529411 |
| Price Hint | 2 |
| Price To Book | 19.680403 |
| Price To Sales Trailing12 Months | 4,545.555 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.225 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 2.89 |
| Regular Market Change Percent | 14.0907 |
| Regular Market Day High | 23.4 |
| Regular Market Day Low | 21.3 |
| Regular Market Day Range | 21.3 - 23.4 |
| Regular Market Open | 21.3 |
| Regular Market Previous Close | 20.51 |
| Regular Market Price | 23.4 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 249,890 |
| Return On Assets | -0.42367 |
| Return On Equity | -0.74448997 |
| Revenue Per Share | 0.005 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 67,989,078 |
| Shares Percent Shares Out | 0.0429 |
| Shares Short | 2,915,409 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,532,229 |
| Short Name | Pulse Biosciences, Inc |
| Short Percent Of Float | 0.162 |
| Short Ratio | 11.2 |
| Source Interval | 15 |
| State | FL |
| Symbol | PLSE |
| Target High Price | 30.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 30.0 |
| Target Median Price | 30.0 |
| Total Cash | 80,735,000 |
| Total Cash Per Share | 1.187 |
| Total Debt | 7,530,000 |
| Total Revenue | 350,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 16.80385 |
| Two Hundred Day Average Change | 6.5961494 |
| Two Hundred Day Average Change Percent | 0.39253798 |
| Type Disp | Equity |
| Volume | 249,890 |
| Website | https://www.pulsebiosciences.com |
| Zip | 33,131 |